Evaxion A/S (EVAX)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Artificial Intelligence-Immunology Powered Vaccines	3.34M
Artificial Intelligence-Immunology Powered Vaccines Growth	4480.82%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Denmark	3.34M
Denmark Growth	4480.82%